Proactive - Interviews for investors

Todos Medical CEO Gerald Commissiong tells Proactive the group, along with its 3CL biology-focused joint venture partner NLC Pharma Limited have announced positive interim data for the Tollovir Phase 2 clinical trial for severe and critical hospitalized coronavirus patients.

Commissiong says Tollovir met its primary endpoint of reducing time to clinical improvement as measured by the National Emergency Warning System 2. In fact, the primary endpoint of time to clinical improvement was reached with average reduction of 2.7 days in the Tollovir group, compared to the placebo group.

Sureserve Group PLC chief executive Peter Smith joined Proactive's Stephen Gunnion with details of the social housing energy services group's full-year 2021 financial results.

Sureserve grew revenue 24.7% to £244 million in the year to 30 September 2021, with profit before tax soaring 76.7% to £13.8 million.

Smith telling Proactive that Sureserve held back on a dividend as it invests in growth, targeting strategically "enhancing acquisitions".

The Good Shroom Co Inc CEO Eric Ronsse talked to Proactive on the group's highlights of 2021, including refining its product offering, expanding sales channels, and strengthening its sales force for the Teonan Beverage line.

Ronsse says the group is ''off to a good start" with sales momentum regarding its hash product, Nordique Royale's Afghan Gold, which he says is generating 'good revenues' of almost $300,000 in sales in its first month.

Harvest One’s President and Chief Executive Officer Gord Davey spoke to Proactive about how management has transitioned the company and their brands Dream Water and LivRelief into a global group that develops and distributes health and wellness products.

Harvest One’s products are focused on treating sleep, pain, and anxiety disorders, and are sold over the counter on retail and e-commerce platforms, while its cannabis-infused LivRelief Topical is sold in Canada at regulated store fronts and medical channels. Davey says this business model has proven to be successful given the improved profit margins it is generating and feedback from its customers.

Numinus Wellness CEO Payton Nyquvest joined Steve Darling from Proactive to share news the company has completed key steps to prepare to enroll participants at its clinics participating in a multi-site MDMA-assisted psychotherapy for PTSD.

Nyquvest telling Proactive the Canadian study sites have recently received regulatory authorization from Health Canada, ethical approval from an Institutional Review Board and a Section 56 exemption from the Controlled Drug and Substance Act which will allow the use of MDMA throughout the duration of the clinical trial.

The trial will be open to eligible participants who were previously enrolled in the placebo arm of the parent study or who were not able to receive treatment due to COVID-19 restrictions.

NexTch AR Solutions CEO Evan Gappelberg joined Steve Darling from Proactive to share news it’s Shopify App is now live and available the App Store.

Gapplberg telling Proactive this now extends the Company's 3D model creation capabilities to Shopify merchants. Those merchants will enjoy one click integration for 3D model making as more ecommerce businesses are looking for 3D models at an affordable price and at scale.

The company is also looking to expand this self-service SaaS offering directly into additional major e-commerce platforms.

Southern Energy CEO Ian Atkinson joined Steve Darling from Proactive to share news the company has started their 2022 exploration program with the start of drilling of three wells into the Gwinville gas field.

Atkinson shares with Proactive more about the state of the program and also the relevance is it that the wells are horizontal rather than vertical. Atkinson also talks about what else is ahead for the company in 2022.

Anglo Pacific Group CEO Julian Treger joined Steve Darling to share news the company has released their financial number for the 4th quarter and year end and the company continues to see record numbers. Treger talks more about the numbers and also about cobalt prices which is a big factor.

Treger also shared with Proactive more on the look for a new CEO as Treger is schedule to leave the company in the coming months.

ProcureAM CEO Andrew Chanin caught up with Proactive New York to discuss December 2021 space economy activity.

What's more, Chanin says its Procure Space ETF and the co-created Procure Space UCITS ETF under the HANetf name has undergone a reconstitution of its holdings, removing one, and adding eight space-focused companies, with seven recently de-SPAC'd companies.

Universal Ibogaine CEO Nick Karos joined Steve Darling from Proactive to share news the company has entered into an agreement with Psygen Labs to secure a supply of GMP ibogaine for use in its planned future clinical trial for opioid use disorder and ongoing ibogaine detox treatments at its clinics.

Karos telling Proactive, this agreement covers basic terms as to pricing, manufacture, and delivery of ibogaine that will be required, based on the ultimate size of the patient group required for the planned clinical trials.